EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.2.1.2 | Acatalasia |
11390181 |
Relationship between posttranslational modification of transaldolase and catalase deficiency in UV-sensitive repair-deficient xeroderma pigmentosum fibroblasts and SV40-transformed human cells. |
causal interaction
ongoing research
unassigned |
2
2
0 |
| 2.2.1.2 | Alopecia |
28409271 |
Unique presentation of cutis laxa with Leigh-like syndrome due to ECHS1 deficiency. |
causal interaction
unassigned |
4
0 |
| 2.2.1.2 | Anemia |
19299175 |
Transaldolase deficiency in two new patients with a relative mild phenotype. |
causal interaction
unassigned |
4
0 |
| 2.2.1.2 | Anemia |
24497183 |
Clinical and molecular characteristics of two transaldolase-deficient patients. |
causal interaction
diagnostic usage
unassigned |
4
4
0 |
| 2.2.1.2 | Anemia |
26238251 |
Transaldolase Deficiency: A New Case Expands the Phenotypic Spectrum. |
causal interaction
diagnostic usage
unassigned |
4
3
0 |
| 2.2.1.2 | Anemia, Hemolytic |
21913417 |
[A newly discovered metabolic diseases due to defects in the pentose pathway]. |
causal interaction
unassigned |
4
0 |
| 2.2.1.2 | arylsulfatase (type i) deficiency |
27106218 |
Antenatal manifestations of inborn errors of metabolism: autopsy findings suggestive of a metabolic disorder. |
causal interaction
unassigned |
4
0 |
| 2.2.1.2 | aspartate-ammonia ligase deficiency |
27106218 |
Antenatal manifestations of inborn errors of metabolism: autopsy findings suggestive of a metabolic disorder. |
causal interaction
unassigned |
4
0 |
| 2.2.1.2 | Autoimmune Diseases |
33848380 |
High Transaldolase 1 expression predicts poor survival of patients with upper tract urothelial carcinoma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
2 |
| 2.2.1.2 | Breast Neoplasms |
34282517 |
SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
4
2
4 |
